Development of potent monoclonal antibody auristatin conjugates for cancer therapy. [electronic resource]
Producer: 20040406Description: 778-84 p. digitalISSN:- 1087-0156
- Adenocarcinoma -- drug therapy
- Animals
- Antibodies, Monoclonal -- adverse effects
- Antineoplastic Agents -- adverse effects
- Cells, Cultured -- drug effects
- Drug Delivery Systems -- methods
- Drug Stability
- Humans
- Immunotoxins -- adverse effects
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Mice, SCID
- Neoplasm Transplantation
- Oligopeptides -- adverse effects
- Protein Binding
- Treatment Outcome
No physical items for this record
Publication Type: Evaluation Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.